DeepCurrents Investment Group »

Travere Therapeutics shares owned by DeepCurrents Investment Group

Quarter-by-quarter ownership of Travere Therapeutics shares owned by DeepCurrents Investment Group from 13F filings

Historical chart of DeepCurrents Investment Group investment in Travere Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Travere Therapeutics held by DeepCurrents Investment Group consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Travere Therapeutics by DeepCurrents Investment Group

Quarter filed Position value Share count Share price at filing
2024-09-30 $1.3M 1.5M 0.87
2024-06-30 $1.3M 2.0M 0.63
2022-06-30 $1.9M 1.9M 1.00
2022-03-31 $24M 22M 1.07

More positions owned by DeepCurrents Investment Group

Western Digital Put Option (WDC)
Trip Com Group Ads Put Option (TCOM)
BioMarin Pharmaceutical Call Option (BMRN)
Sea Note 2.375%12/0 (Principal)
United States Steel Corporation Call Option (X)
Shift4 Pmts Note 12/1 (Principal)
Cinemark Hldgs Note 4.500% 8/1 (Principal)
Nova Note 10/1 (Principal)
Axon Enterprise Note 0.500%12/1 (Principal)
Livent Corp Note 4.125% 7/1 (Principal)
Insight Enterprises Note 0.750% 2/1 (Principal)
Insulet Corp Note 0.375% 9/0 (Principal)
Novocure Note 11/0 (Principal)
Zscaler Note 0.125% 7/0 (Principal)
Block Note 0.125% 3/0 (Principal)

View all positions for DeepCurrents Investment Group

Top funds holding Travere Therapeutics

Linden Advisors
D. E. Shaw & Co
Wolverine Asset Management
Graham Capital Management
Ing Investment Management
Point72 Asset Management
Oaktree Capital Management
SSI Investment Management
Affinity Asset Advisors
Capstone Investment Advisors
Readystate Asset Management
Henderson Group
BlackRock
Morgan Stanley
Agf Management

View all funds holding Travere Therapeutics